Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 125   

Articles published

JNJ 125.11 +0.22 (0.18%)
price chart
Johnson & Johnson: Patience Finally Beginning To Pay Off
Johnson & Johnson (NYSE:JNJ) is a stock that has started to liftoff significantly this year, in spite of price remaining more or less stagnant over the past two years.
Johnson & Johnson: 1 Dividend Stock to Own Forever  Profit Confidential
Rockland Trust Co Lowers stake in Johnson & Johnson (JNJ)  TheFounders Daily
3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings
Johnson & Johnson (NYSE:JNJ) is a healthcare Goliath that operates consumer healthcare, pharmaceuticals, and medical device businesses.
Why I'm Easing Off Johnson & Johnson  Seeking Alpha
Can Big Still Be Beautiful?
For the 56-year-old CEO of Johnson & Johnson, this drizzly morning in May—Analyst Day—offered a chance to put some show behind a tell he had been making for the previous four years, or since he had assumed the reins of the $70-billion-a-year health ...
Johnson & Johnson Subsidiary Acclarent Settles Medical Device-Related ...
J&J's subsidiary Acclarent pays $18 million in U.S. court settlement to resolve accusations related to an unapproved medical device.
Johnson & Johnson's Acclarent Unit in $18 Million US Settlement  Wall Street Journal
Johnson & Johnson subsidiary pays $18 million to U.S. in settlement  UPI.com
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (Symbol: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Johnson & Johnson: Great Quality, But Stock Has No Margin Of Safety
This piece is in response to Bob Ciura's article where he states that Johnson & Johnson is a quality stock and that it is “cheap”.
3 Big Stock Charts for Tuesday: Lockheed Martin Corporation (LMT), Johnson ...
The market's volatility through 2016 hasn't spread to all stocks. As a matter of fact, there are a number of low-volatility stocks that have been pressing to new all-time highs while the rest of the market has gyrated in their own ranges.
Two Former Johnson & Johnson Execs Just Got Convicted for Improper Marketing
A federal jury on Wednesday convicted two former top executives at medical device company Acclarent, a unit of drug giant Johnson & Johnson JNJ -0.10% , for improperly marketing a sinus-opening device. The Boston jury found Facteau and Fabian guilty ...
Johnson & Johnson (JNJ) Closes 0.11% Down on the Day for July 25
Dow Jones component Johnson & Johnson (JNJ) saw its stock move -0.11% to $124.89, representing a per-share move of $0.14, on volume of 4.87 million shares for Monday.
Ranir acquires dental products brand from Johnson & Johnson
GRAND RAPIDS - Ranir LLC, a producer of store-brand and oral-care products, acquired the Rembrandt teeth-whitening brand from Johnson & Johnson Consumer Inc. The acquisition adds to Grand Rapids-based Ranir's product portfolio. The company ...